1. Biologics Control Act(1902).https://www.usp.org/sites/default/files/fda‐exhibit/legislation/1902.html(accessed 08 July 2019).
2. A brief history of the GMPs for pharmaceuticals;Immel B.K.;Pharmaceutical Technology,2001
3. ICH Harmonised Tripartite Guideline ICH M4. (2017)Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk.https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf(accessed 08 July 2019).
4. ICH Harmonised Tripartite Guideline ICH Q3D. (2019).Guideline for elemental impurities.https://database.ich.org/sites/default/files/Q3D‐R1EWG_Document_Step4_Guideline_2019_0322.pdf(accessed 08 July 2019).